Series D - BillionToOne
Investment Firm
Overview
BillionToOne is a precision diagnostics company that focuses on genetic testing for disease detection.
Announced Date
Jun 21, 2024
Funding Type
Series D
Highlights
Location
United States, North America
Social
Participant Investors
7
Round Details and Background
BillionToOne raised $130000000 on 2024-06-21 in Series D
BillionToOne is a precision diagnostics company that focuses on genetic testing for disease detection.
Company Funding History
9
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Dec 15, 2022 |  Series C - BillionToOne | 8 | - | 48.5M |
| Dec 15, 2022 | Debt Financing - BillionToOne | 1 | - | 35.0M |
| Jun 21, 2024 | Series D - BillionToOne | 8 | - | 130.0M |
| Sep 15, 2017 | Seed Round - BillionToOne | 8 | - | 2.4M |
Recent Activity
There is no recent news or activity for this profile.